Skip to main content
Top
Published in: Annals of Hematology 2/2010

01-02-2010 | Erratum

Erratum to: Results of FLT3 mutation screening and correlations with immunophenotyping in 169 Brazilian patients with acute myeloid leukemia

Authors: Antonio R. Lucena-Araujo, Danielle L. Souza, Fabio Morato de Oliveira, Mariana Tereza Lira Benicio, Lorena L. Figueiredo-Pontes, Barbara A. Santana-Lemos, Guilherme A. dos Santos, Rafael H. Jacomo, Anemari R. Dinarte-Santos, Mihoko Yamamoto, Wilson A. Silva-Jr, Maria de Lourdes Chauffaille, Eduardo M. Rego

Published in: Annals of Hematology | Issue 2/2010

Login to get access

Excerpt

Erratum to: Ann Hematol
Metadata
Title
Erratum to: Results of FLT3 mutation screening and correlations with immunophenotyping in 169 Brazilian patients with acute myeloid leukemia
Authors
Antonio R. Lucena-Araujo
Danielle L. Souza
Fabio Morato de Oliveira
Mariana Tereza Lira Benicio
Lorena L. Figueiredo-Pontes
Barbara A. Santana-Lemos
Guilherme A. dos Santos
Rafael H. Jacomo
Anemari R. Dinarte-Santos
Mihoko Yamamoto
Wilson A. Silva-Jr
Maria de Lourdes Chauffaille
Eduardo M. Rego
Publication date
01-02-2010
Publisher
Springer-Verlag
Published in
Annals of Hematology / Issue 2/2010
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-009-0860-1

Other articles of this Issue 2/2010

Annals of Hematology 2/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine